Chapter 22 of 25
What you will learn
- Recognize common effects of surgery, radiation and medicines.
- Identify urgent symptoms and obtain a written action plan.
- Find help for menopause, nutrition, fatigue and distress.
Chemotherapy and targeted-treatment effects
Nausea, constipation or diarrhoea, hair loss, low blood counts and fatigue can occur with chemotherapy. Paclitaxel can cause neuropathy: tingling, numbness, pain or difficulty with balance and fine tasks. Report functional changes early because modifying treatment may reduce further injury. Supportive medicines work best when taken according to the prescribed schedule, including prevention before symptoms become severe.
Lenvatinib requires attention to blood pressure, hydration, weight, thyroid function and urine protein. Persistent diarrhoea or poor intake can cause dehydration and kidney problems. Do not independently stop and restart medicines repeatedly; use the team's hold and contact instructions. Tell all clinicians about supplements and over-the-counter products.
Immunotherapy warning signs
Checkpoint inhibitors can cause inflammation in almost any organ. New cough, breathlessness, persistent diarrhoea, jaundice, severe weakness, headache, confusion or unusual thirst needs prompt assessment. Thyroid, adrenal or pituitary problems may present as fatigue rather than an obvious emergency. Effects can occur after treatment has ended.
Do not assume symptoms are simply infection, ageing or ordinary chemotherapy effects. Contact the oncology team and tell emergency clinicians which immunotherapy was given and when. Steroids may be needed for certain toxicities, but their choice and dose require medical assessment; self-treatment can delay diagnosis or worsen another cause.
Recovery, menopause and pelvic health
Removing ovaries or pelvic radiation can cause early menopause, with hot flushes, sleep disruption, vaginal dryness and bone-health consequences. Nonhormonal measures and selected hormonal options should be discussed according to cancer type, treatment and individual risk. There is no universal rule that all survivors must endure symptoms without help or that every hormonal product is safe for everyone.
Vaginal narrowing or pain after radiation may improve with tailored dilator guidance, moisturizers, lubricants and pelvic-floor therapy after healing. Sexual intimacy can be adapted to comfort and preferences. Lymphoedema may follow node surgery or radiation; new persistent leg swelling deserves assessment, including exclusion of a clot, before specialist compression and rehabilitation advice.
Red flags
| Symptom | Action |
|---|---|
| Fever around 38°C or above during chemotherapy, shaking chills or severe illness | Contact the treatment emergency service immediately |
| Sudden chest pain, severe breathlessness, collapse or confusion | Seek emergency care |
| Heavy bleeding with faintness | Seek urgent emergency assessment |
| Severe diarrhoea, inability to drink, very little urine | Contact the team urgently |
| New neurological weakness or severe headache on immunotherapy | Obtain urgent assessment |
Follow any stricter threshold supplied by your centre. Feeling seriously unwell can be urgent even with a normal temperature.
Nutrition, activity and emotional support
Aim for adequate energy, protein and fluids using foods that are affordable and tolerable. A dietitian can help with weight loss, poor appetite, diabetes or bowel symptoms. Unproven anticancer diets and high-dose supplements can cause harm or interactions. Gentle activity and gradual strengthening can help fatigue, but persistent exhaustion warrants evaluation for anaemia, endocrine problems, sleep or mood disorders.
Ask for psychological, social-work or palliative-care support when distress, finances or caregiving demands become difficult. Family members can help record symptoms and organize appointments with your permission. Obtain a written list of daytime and out-of-hours contacts; supportive care should be part of treatment from the beginning.
Related chapters
- Follow-Up, Surveillance and Recurrence Detection
- Molecular Classification: The Four Major Groups
- How Doctors Choose Treatment
References and review status
- NCI: Side Effects of Cancer Treatment
- ESGO–ESTRO–ESP endometrial carcinoma guideline update, 2025
- ASCO Palliative Care guideline update, 2024
- DailyMed: Lenvima prescribing information
- FDA pembrolizumab–chemotherapy approval / KEYNOTE-868, June 2024
Evidence/editorial check: 30 October 2026. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.
Evidence scope and update policy